128 related articles for article (PubMed ID: 8432311)
1. Ca2+ channel blocking activity of lacidipine and amlodipine in A7r5 vascular smooth muscle cells.
Spampinato S; Bachetti T; Carboni L; Ratti E; Van Amsterdam FT; Ferri S
Eur J Pharmacol; 1993 Jan; 244(2):139-44. PubMed ID: 8432311
[TBL] [Abstract][Full Text] [Related]
2. Radioligand and functional estimates of the interaction of the 1,4-dihydropyridines, isradipine and lacidipine, with calcium channels in smooth muscle.
Salomone S; Godfraind T
Br J Pharmacol; 1993 May; 109(1):100-6. PubMed ID: 8495233
[TBL] [Abstract][Full Text] [Related]
3. Calcium channel blocking properties of amlodipine in vascular smooth muscle and cardiac muscle in vitro: evidence for voltage modulation of vascular dihydropyridine receptors.
Burges RA; Gardiner DG; Gwilt M; Higgins AJ; Blackburn KJ; Campbell SF; Cross PE; Stubbs JK
J Cardiovasc Pharmacol; 1987 Jan; 9(1):110-9. PubMed ID: 2434785
[TBL] [Abstract][Full Text] [Related]
4. The hemodynamic effects of lacidipine in anesthetized dogs: comparison with nitrendipine, amlodipine, verapamil, and diltiazem.
Quartaroli M; Gambini F; Tarter G; Micheli D; Trist DG; Gaviraghi G
J Cardiovasc Pharmacol; 1991 Sep; 18(3):326-36. PubMed ID: 1720831
[TBL] [Abstract][Full Text] [Related]
5. Lacidipine: a calcium antagonist with potent and long-lasting antihypertensive effects in animal studies.
Micheli D; Collodel A; Semeraro C; Gaviraghi G; Carpi C
J Cardiovasc Pharmacol; 1990 Apr; 15(4):666-75. PubMed ID: 1691398
[TBL] [Abstract][Full Text] [Related]
6. Effect of S-312, a new calcium channel blocker, on the 1,4-dihydropyridine binding sites in porcine basilar blood vessels and rat aortic smooth muscle cells.
Mihara S; Fujimoto M
Jpn J Pharmacol; 1991 Jul; 56(3):249-59. PubMed ID: 1832726
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
[TBL] [Abstract][Full Text] [Related]
8. Vascular-selective effect of lercanidipine and other 1,4-dihydropyridines in isolated rabbit tissues.
Angelico P; Guarneri L; Leonardi A; Testa R
J Pharm Pharmacol; 1999 Jun; 51(6):709-14. PubMed ID: 10454048
[TBL] [Abstract][Full Text] [Related]
9. Functional interaction of lacidipine with calcium channels in vascular smooth muscle.
Godfraind T; Salomone S
J Cardiovasc Pharmacol; 1991; 18 Suppl 11():S1-6. PubMed ID: 1725443
[TBL] [Abstract][Full Text] [Related]
10. Dihydropyridine-induced Ca2+ release from ryanodine-sensitive Ca2+ pools in human skeletal muscle cells.
Weigl LG; Hohenegger M; Kress HG
J Physiol; 2000 Jun; 525 Pt 2(Pt 2):461-9. PubMed ID: 10835047
[TBL] [Abstract][Full Text] [Related]
11. The actions of azelnidipine, a dihydropyridine-derivative Ca antagonist, on voltage-dependent Ba2+ currents in guinea-pig vascular smooth muscle.
Zhu HL; Tomoda T; Aishima M; Ito Y; Teramoto N
Br J Pharmacol; 2006 Nov; 149(6):786-96. PubMed ID: 17016499
[TBL] [Abstract][Full Text] [Related]
12. Effect of hydrogen peroxide on calcium homeostasis in smooth muscle cells.
Roveri A; Coassin M; Maiorino M; Zamburlini A; van Amsterdam FT; Ratti E; Ursini F
Arch Biochem Biophys; 1992 Sep; 297(2):265-70. PubMed ID: 1497346
[TBL] [Abstract][Full Text] [Related]
13. Effect of serum withdrawal on the contribution of L-type calcium channels (CaV1.2) to intracellular Ca2+ responses and chemotaxis in cultured human vascular smooth muscle cells.
Patel MK; Clunn GF; Lymn JS; Austin O; Hughes AD
Br J Pharmacol; 2005 Jul; 145(6):811-7. PubMed ID: 15880143
[TBL] [Abstract][Full Text] [Related]
14. Vascular reactivity: a measurement of calcium channel blockade.
Elliott HL
J Hum Hypertens; 1995 Mar; 9 Suppl 1():S29-32. PubMed ID: 7783111
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characteristics of NP-252, a new dihydropyridine slow Ca2+ channel blocker, in isolated rabbit vascular smooth muscle and guinea pig myocardium: vascular selectivity.
Shibata S; Satake N; Kodama I; Hester RK; Wang CG; Jino H; Hojo M; Tatsumi H; Gandhi V; Jones DJ
Eur J Pharmacol; 1991 Oct; 203(3):337-44. PubMed ID: 1773820
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibitory action of Biginelli-type dihydropyrimidines on depolarization-induced arterial smooth muscle contraction.
Cernecka H; Veizerova L; Mensikova L; Svetlik J; Krenek P
J Pharm Pharmacol; 2012 May; 64(5):735-41. PubMed ID: 22471370
[TBL] [Abstract][Full Text] [Related]
17. Venodilator effects of pranidipine, a 1,4-dihydropyridine Ca2+ channel antagonist, in rats: comparison with nifedipine and amlodipine.
Hirano T; Ohura M; Orito K; Fujiki H; Miyakoda G; Mori T
Eur J Pharmacol; 1997 Apr; 324(2-3):201-4. PubMed ID: 9145772
[TBL] [Abstract][Full Text] [Related]
18. Effects of a new dihydropyridine calcium antagonist on vascular smooth muscles, cardiac muscles and [3H]-nitrendipine binding.
Miura A; Ukai Y; Matsuzaki T; Taniguchi N; Hayashi S; Kano S; Kimura Y; Kimura K; Enomoto H
Arzneimittelforschung; 1986 Sep; 36(9):1323-8. PubMed ID: 3790181
[TBL] [Abstract][Full Text] [Related]
19. Amlodipine, a new 1,4-dihydropyridine calcium antagonist with a particularly strong antihypertensive profile.
Fleckenstein A; Frey M; Zorn J; Fleckenstein-Grün G
Am J Cardiol; 1989 Nov; 64(17):21I-34I. PubMed ID: 2530884
[TBL] [Abstract][Full Text] [Related]
20. Potassium depolarization elevates cytosolic free calcium concentration in rat anterior pituitary cells through 1,4-dihydropyridine-sensitive, omega-conotoxin-insensitive calcium channels.
Meier K; Knepel W; Schöfl C
Endocrinology; 1988 Jun; 122(6):2764-70. PubMed ID: 2453348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
